A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". Two crossed lines that form an 'X'. It ...

Two Minneapolis-based companies – digital health care management program maker HealthFactors and medical-focused R&D firm Koronis BioMedical Technologies (KBT) – are working together to create new ...

The device is attached to the top of the canister of the patient’s inhaler and works together with the mobile app to monitor and provide feedback. The Food and Drug Administration has cleared the ...

Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les ...

Asthma attacks come with little warning and are often triggered by invisible particles in the air. Now, thanks to advances in Bluetooth technology, smartphones have become the newest weapon in the ...

MILAN -- An electronic monitoring device (EMD) increased adherence to asthma medication in the short-term but still left patients needing more assistance in the long run, a cluster-randomized trial ...

Please provide your email address to receive an email when new articles are posted on . BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, ...

LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...

ATS 2024, San Diego – Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and ...

LONDON--(BUSINESS WIRE)--The smart inhaler technology market is poised to grow by USD 132.66 million during 2020-2024, progressing at a CAGR of almost 43% during the forecast period. Worried about the ...

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40% of academic pulmonary and allergy clinicians have not adopted ...